HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tsui-Er Lee Selected Research

cinnamophilin

12/2021Cinnamophilin overcomes cancer multi-drug resistance via allosterically modulating human P-glycoprotein on both drug binding sites and ATPase binding sites.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tsui-Er Lee Research Topics

Disease

3Neoplasms (Cancer)
06/2022 - 02/2019
1Type 2 Diabetes Mellitus (MODY)
11/2017
1Myocardial Infarction
11/2017
1Myocardial Ischemia (Ischemic Heart Diseases)
11/2017

Drug/Important Bio-Agent (IBA)

3Member 1 Subfamily B ATP Binding Cassette TransporterIBA
06/2022 - 02/2019
2Pharmaceutical PreparationsIBA
06/2022 - 12/2021
1diacereinIBA
06/2022
1Vincristine (Oncovin)FDA LinkGeneric
06/2022
1Cytotoxins (Cytolysins)IBA
06/2022
1rheinIBA
06/2022
1ProdrugsIBA
06/2022
1Adenosine Triphosphatases (ATPase)IBA
12/2021
1cinnamophilinIBA
12/2021
1isotenulinIBA
02/2019
1tenulinIBA
02/2019
1Dipeptidyl-Peptidase IV InhibitorsIBA
11/2017
1Glucagon-Like Peptide 1 (GLP 1)IBA
11/2017
1IncretinsIBA
11/2017

Therapy/Procedure

1Drug Therapy (Chemotherapy)
02/2019
1Therapeutics
11/2017